Evidence map›Paper›PMID 41367480›Full record

ArticleCureus2025

A Study of Adverse Drug Reactions to Antiepileptic Drugs in Pediatric Epileptic Patients From North India.

Puneet Kaur, Anjleen Kaur, Manvir Kaur, Harjinder Singh, Jasbir Singh

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Puneet KaurPharmacology, Government Medical College and Rajindra Hospital, Patiala, IND.
Anjleen KaurPharmacology, Government Medical College and Rajindra Hospital, Patiala, IND.
Manvir KaurPublic Health, Johns Hopkins Bloomberg School of Public Health, Maryland, USA.
Harjinder SinghPediatrics, Government Medical College and Rajindra Hospital, Patiala, IND.
Jasbir SinghPharmacology, Government Medical College and Rajindra Hospital, Patiala, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe primary objective of this study was to evaluate the various adverse drug reactions (ADRs) associated with antiepileptic drugs in children. The secondary objective was to analyze the distribution of these ADRs according to gender, age group, type of epilepsy, and treatment modality. MATERIALS AND

methodsAn observational cross-sectional study was conducted in the pediatric outpatient department of a tertiary care hospital. A total of 100 eligible patients, who fulfilled the inclusion and exclusion criteria, were enrolled in the study after obtaining informed consent. The prescription details and ADRs were collected using a pre-designed proforma and the Pediatric Epilepsy Side-effect Questionnaire, respectively. The collected data were then analyzed using descriptive statistics and the chi-square test, where appropriate. The p-value <0.05 was considered statistically significant.

resultsA total of 67 ADRs were reported in 42 participants, predominantly in males (71.43%). Polytherapy (75%) was associated with a higher number of ADRs (p=0.002). Patients treated with valproate (monotherapy group) and valproate with clobazam (polytherapy group) reported a greater number of ADRs (57.14%, 72.73%).

conclusionsThe study highlights that ADRs are more common in patients on conventional drugs like valproate, either as monotherapy or polytherapy. Use of newer drugs by physicians and reporting of ADRs by patients should be encouraged for the comprehensive management of childhood epilepsy.

Indexed as

adverse drug reactions (adr)antiepileptic drugs (aed)epilepsy in childrennorth indiaside‐effect

Identifiers

PMID41367480
PMCPMC12682936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.